Aterian (NASDAQ:ATER – Get Free Report) was upgraded by research analysts at Wall Street Zen to a “hold” rating in a research note issued to investors on Saturday.
Separately, Weiss Ratings raised Aterian from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Tuesday, May 19th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock presently has an average rating of “Sell”.
View Our Latest Stock Analysis on Aterian
Aterian Stock Up 0.4%
Aterian (NASDAQ:ATER – Get Free Report) last announced its quarterly earnings data on Friday, May 15th. The company reported ($0.39) EPS for the quarter, topping analysts’ consensus estimates of ($0.69) by $0.30. Aterian had a negative return on equity of 82.05% and a negative net margin of 39.56%.The business had revenue of $0.02 million during the quarter, compared to analysts’ expectations of $15.82 million.
Hedge Funds Weigh In On Aterian
Several institutional investors and hedge funds have recently made changes to their positions in the company. Goldman Sachs Group Inc. increased its position in shares of Aterian by 73.0% in the 1st quarter. Goldman Sachs Group Inc. now owns 21,392 shares of the company’s stock valued at $45,000 after buying an additional 9,026 shares in the last quarter. XTX Topco Ltd acquired a new stake in Aterian during the 2nd quarter worth $55,000. Citadel Advisors LLC lifted its holdings in Aterian by 222.0% during the third quarter. Citadel Advisors LLC now owns 33,165 shares of the company’s stock worth $35,000 after acquiring an additional 22,865 shares in the last quarter. Finally, Susquehanna International Group LLP lifted its holdings in Aterian by 310.2% during the third quarter. Susquehanna International Group LLP now owns 40,512 shares of the company’s stock worth $43,000 after acquiring an additional 30,637 shares in the last quarter. Institutional investors and hedge funds own 7.02% of the company’s stock.
Aterian Company Profile
Aterian Inc is a technology-driven consumer products company that leverages artificial intelligence and machine learning to develop, source and market branded household, health and personal care products. Through its proprietary data analytics platform, Aterian identifies emerging trends, forecasts demand and optimizes product selection, pricing and distribution. The company maintains a vertically integrated supply chain, overseeing manufacturing partnerships and logistics to support rapid product development and market entry.
Aterian’s portfolio spans a range of categories including home and kitchen, health and wellness, baby care, beauty tools and electronics accessories.
Further Reading
- Five stocks we like better than Aterian
- Rocket Lab’s NASA Win Tests Key Support After Sharp Pullback
- AST SpaceMobile Just Nailed a Major Launch—So Why Is the Stock Crashing?
- Palantir’s Valuation Problem Just Met 2 New Growth Catalysts
- Xcel Energy Stock Offers Stability as Electricity Demand Builds
Receive News & Ratings for Aterian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aterian and related companies with MarketBeat.com's FREE daily email newsletter.
